Igene Biotechnology, Inc. (IGNE)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Mar 6, 2026, 4:00 PM EST
Igene Biotechnology Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 | 2004 - 2000 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '10 Sep 30, 2010 | Dec '09 Dec 31, 2009 | Dec '08 Dec 31, 2008 | Dec '07 Dec 31, 2007 | Dec '06 Dec 31, 2006 | Dec '05 Dec 31, 2005 | 2004 - 2000 |
| Net Income | -2.37 | -0.14 | -3.99 | -1.9 | -2.43 | -2.04 | Upgrade
|
| Depreciation & Amortization | 0.17 | 0.18 | 0.37 | 0.01 | 0.02 | 0.02 | Upgrade
|
| Other Amortization | 0.01 | 0.01 | 1.29 | 1.41 | 1.28 | 0.62 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | -0.01 | - | 0.11 | Upgrade
|
| Loss (Gain) on Equity Investments | 1.73 | 1.09 | - | 0.11 | 0.11 | 0.37 | Upgrade
|
| Stock-Based Compensation | 0.05 | - | - | 0.02 | 0.08 | - | Upgrade
|
| Other Operating Activities | -2.96 | -3.34 | 0.01 | 0.01 | 0.01 | 0.38 | Upgrade
|
| Change in Accounts Receivable | 0.03 | 1.04 | 1.67 | -3.7 | 0.01 | 0.07 | Upgrade
|
| Change in Inventory | -0 | 2.4 | 5.66 | 1.81 | - | - | Upgrade
|
| Change in Accounts Payable | 1.63 | -1.33 | -4.33 | 3.57 | 0.9 | 0.77 | Upgrade
|
| Change in Other Net Operating Assets | 0.03 | -0.02 | 0.01 | -0.02 | 0.03 | -0.01 | Upgrade
|
| Operating Cash Flow | -1.68 | -0.1 | 0.71 | 1.31 | 0 | 0.29 | Upgrade
|
| Operating Cash Flow Growth | - | - | -46.16% | 1310365.00% | -99.97% | -4.38% | Upgrade
|
| Capital Expenditures | 0.02 | -0.17 | -0.23 | -0.28 | - | - | Upgrade
|
| Sale of Property, Plant & Equipment | 0 | - | - | 0.02 | - | - | Upgrade
|
| Investment in Securities | - | - | - | -0.11 | -0.11 | -0.37 | Upgrade
|
| Investing Cash Flow | 0.02 | -0.17 | -0.23 | -0.36 | -0.11 | -0.37 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 0.76 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | - | - | -0.71 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | 0.06 | - | - | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 0.01 | - | Upgrade
|
| Financing Cash Flow | - | - | - | 0.06 | 0.01 | - | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.01 | 0.08 | -0.02 | - | - | - | Upgrade
|
| Net Cash Flow | -1.65 | -0.19 | 0.46 | 1 | -0.1 | -0.08 | Upgrade
|
| Free Cash Flow | -1.67 | -0.27 | 0.48 | 1.04 | 0 | 0.29 | Upgrade
|
| Free Cash Flow Growth | - | - | -53.69% | 1035285.00% | -99.97% | -4.38% | Upgrade
|
| Free Cash Flow Margin | -34666.49% | -6.79% | 6.27% | 45.28% | - | - | Upgrade
|
| Free Cash Flow Per Share | -0.00 | - | 0.00 | 0.01 | - | 0.00 | Upgrade
|
| Cash Interest Paid | - | - | - | 0.06 | 0.04 | 0.09 | Upgrade
|
| Levered Free Cash Flow | -0.44 | -0.21 | 1.1 | -3.33 | 0.03 | 0.07 | Upgrade
|
| Unlevered Free Cash Flow | -0.41 | -0.16 | 1.07 | -3.36 | 0.07 | 0.37 | Upgrade
|
| Change in Working Capital | 1.69 | 2.09 | 3.02 | 1.66 | 0.94 | 0.83 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.